Eating nuts may help colon cancer survive

Share This Post

According to the CALGB 8903 study published in the Journal of Clinical Oncology, patients with stage III colon cancer who eat at least 2 servings of nuts per week have higher disease-free survival (DFS) and overall survival (OS). The association between total nut intake and improved outcomes is consistent among other known or suspected risk factors for cancer recurrence and death.

Dr. Charles S. Fuchs of the Yale Cancer Center and colleagues wrote: “This prospective study of patients with stage III colon cancer shows that a diet with increased nut consumption is associated with a significant reduction in cancer recurrence and mortality. Although we observed The results of sex studies cannot determine causality, but the results further support diet and lifestyle as modifiable risk factors for patients with colon cancer. “

This study conducted a 6.5-year follow-up survey of 826 colon cancer patients treated with surgery and chemotherapy. The results showed that people who consumed at least two ounces of nuts per week had a 42% increase in disease-free survival and an increase in overall survival. 57%.

The researchers said: “Further analysis of the cohort showed that the disease-free survival of participants who consumed nuts significantly increased. Nuts include almonds, walnuts, hazelnuts, cashews, walnuts, etc. On the contrary, peanuts are actually a type of bean food . These results are consistent with other observational studies that show that a range of health behaviors, including increasing physical activity, maintaining a healthy weight, and lower intake of sugar and sweet drinks can increase the survival rate of colon cancer. “

The findings emphasize the importance of diet and lifestyle factors in the survival of colon cancer. In addition, the researchers emphasized that the study emphasized the connection between biological mechanisms of not only colon cancer but also certain chronic diseases, such as type 2 diabetes, which worsens the disease.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient A case report
CAR T-Cell therapy

Claudin18.2-targeted CAR-T cell therapy brings complete remission in advanced pancreatic cancer patient : A case report

Claudin18.2-targeted CAR-T cell therapy has shown remarkable potential in treating advanced pancreatic cancer, as highlighted in a recent case report. This innovative approach led to complete remission in a patient with advanced disease, underscoring the promise of targeted immunotherapy. By leveraging the specific expression of Claudin18.2 on cancer cells, this therapy offers a precision-based treatment, heralding a new era in pancreatic cancer management with significant clinical implications.

What is the treatment after BCMA CAR T failed in RR multiple myeloma cases
CAR T-Cell therapy

What is the treatment after BCMA CAR T failed in R/R multiple myeloma cases?

For people with relapsed or refractory multiple myeloma, BCMA CAR T-cell therapy might not work. Other treatments, such as bispecific antibodies, other CAR T-cell therapies that target different antigens, and combination regimens with immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies, can still be used. OriCAR-017 is another immunotherapy that is under trial and is expected to be launched soon. Clinical trials offer experimental treatments, providing access to novel therapies. Tailored approaches based on patient-specific factors and emerging research are crucial for improving outcomes in this challenging scenario.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy